TipRanks
Advertisement
Advertisement
Caribou Biosciences Shareholders Decide Key Governance Matters
PremiumCompany AnnouncementsCaribou Biosciences Shareholders Decide Key Governance Matters
4M ago
Analyst Reiterates Buy on Caribou, Citing Strong vispa-cel Data and Pivotal ANTLER-3 Upside; Price Target Maintained at $11
Premium
Ratings
Analyst Reiterates Buy on Caribou, Citing Strong vispa-cel Data and Pivotal ANTLER-3 Upside; Price Target Maintained at $11
4M ago
Analyst Reiterates Buy on Caribou Biosciences, Keeps $8 Price Target After Encouraging Allo CAR-T Data
Premium
Ratings
Analyst Reiterates Buy on Caribou Biosciences, Keeps $8 Price Target After Encouraging Allo CAR-T Data
4M ago
Caribou Biosciences price target raised to $11 from $9 at H.C. Wainwright
PremiumThe FlyCaribou Biosciences price target raised to $11 from $9 at H.C. Wainwright
5M ago
Caribou Biosciences Gains RMAT Status for CB-011 Therapy
Premium
Company Announcements
Caribou Biosciences Gains RMAT Status for CB-011 Therapy
6M ago
Caribou CB-011 granted Regenerative Medicine Advanced Therapy designation
Premium
The Fly
Caribou CB-011 granted Regenerative Medicine Advanced Therapy designation
6M ago
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
PremiumMarket NewsHere is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
8M ago
Caribou Biosciences initiated with a Buy at Clear Street
Premium
The Fly
Caribou Biosciences initiated with a Buy at Clear Street
8M ago
Caribou Biosciences price target lowered to $6 from $8 at BofA
Premium
The Fly
Caribou Biosciences price target lowered to $6 from $8 at BofA
9M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―